Cytophage Technologies Ltd. (TSXV:CYTO)
Canada · Delayed Price · Currency is CAD 0.1800
-0.0100 (-5.26%)
At close: Jan 19, 2026
Cytophage Technologies Market Cap
Cytophage Technologies has a market cap or net worth of CAD 12.18 million as of January 20, 2026. Its market cap has decreased by -29.41% in one year.
Market Cap
12.18M
Enterprise Value
13.21M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.18
Market Cap Chart
Since February 4, 2022, Cytophage Technologies's market cap has increased from 5.25M to 12.18M, an increase of 132.06%. That is a compound annual growth rate of 23.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 12.18M | 20.00% |
| Dec 31, 2025 | 10.15M | -36.19% |
| Dec 31, 2024 | 15.91M | 478.58% |
| Dec 23, 2022 | 2.75M | -47.62% |
| Feb 4, 2022 | 5.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.85B |
| Green Thumb Industries | 2.61B |
| dentalcorp Holdings | 2.20B |
| Sienna Senior Living | 2.15B |
| Extendicare | 2.13B |
| Trulieve Cannabis | 2.02B |
| Cronos Group | 1.35B |
| Bright Minds Biosciences | 1.20B |